(Q48530200)

English

ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures.

scientific article published on 18 May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

Young Hae Chong

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

Yoo Jeong Shin

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

Eun Ok Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

Rakez Kayed

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

Charles G Glabe

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

Andrea J Tenner

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

language of work or name

0 references

publication date

18 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

281

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

29

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

20315-20325

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Pathways towards and away from Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Deciphering the molecular basis of memory failure in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Femtomole Immunodetection of Synthetic and Endogenous Amyloid-β Oligomers and Its Application to Alzheimer's Disease Drug Candidate Screening

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Tau is essential to beta -amyloid-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Stability of the preclinical episodic memory deficit in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

A specific amyloid-beta protein assembly in the brain impairs memory

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Neuronal activity regulates gabaa receptor subunit expression in organotypic hippocampal slice cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Identification of the critical features of a small peptide inhibitor of JNK activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Alzheimer's disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by beta-amyloid

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The changing landscape of ischaemic brain injury mechanisms.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Mechanisms of neurodegenerative disorders: Part 2: control of cell death.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Soluble oligomeric Abeta disrupts the protein kinase C signaling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

A role for ERK MAP kinase in physiologic temporal integration in hippocampal area CA1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Preserved synaptic vesicle recycling in hippocampal neurons in a mouse Alzheimer's disease model.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Identifiers

10.1074/JBC.M601016200

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16714296

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48530200&oldid=1588020412"